The underlying biologic cause for platinum resistance has been explored for decades and is likely a multifactorial process mediated by drug transport, tolerance of cancer cells to DNA damage, loss of p53 function, and evasion of apoptosis, among others [29]. The gene discussed is TP53; the disease is cancer.